Ready-to-use oncology treatment used for multiple myeloma and mantle cell lymphoma Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) and Shilpa Medicare Limited ...
GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market.
Correspondence to Dr Falk Hiepe, Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Charitéplatz 1, Berlin 10117, Germany; falk.hiepe{at}charite.de Objectives To ...
Department of Hematology, Qilu Hospital of Shandong University, Jinan, China Autoimmune hemolytic anemia (AIHA) is a type of hemolytic anemia. In this condition, the body produces anti-red blood cell ...
India Ratings and Research has upgraded Blue Dart Express Ltd's Long-Term Issuer Rating to 'IND AA+' from 'IND AA'. The ...
Godrej Properties Ltd has purchased ~10 acres of land in Yelahanka, Bengaluru to develop ~1.5 million square feet of saleable ...
DARZALEX has significant market potential as a leading monoclonal antibody for multiple myeloma treatment. Its approval in various combinations for both newly diagnosed and relapsed/refractory ...
Louisiana is preparing this week to execute a man by nitrogen gas, the first execution in the state in 15 years HOUSTON -- Louisiana is set this week to execute a man by nitrogen gas, the first ...
TAMPA — The Yankees are not yet at the point of “last resort” with Giancarlo Stanton’s elbows. But when he might be available to the Yankees, or even resume baseball activities, remains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results